Insider Trading History of Marcus Joel S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Marcus Joel S since 2005. This trader's CIK number is 1216955. At the time of last reporting, Marcus Joel S was the Officer of Intra-cellular Therapies, Inc.. (stock ticker symbol ITCI). Also see all insider trading activities at Intra-cellular Therapies, Inc..

Note that in the past MARCUS JOEL S also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Alexandria Real Estate Equities, Inc. (ARE) by Marcus Joel S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 ARE 0 $0 7,500 $891,900 0 $0
2023 ARE 0 $0 16,500 $2,428,500 0 $0
2022 ARE 0 $0 6,500 $975,000 0 $0
2021 ARE 0 $0 52,500 $10,177,325 0 $0
2020 ARE 0 $0 147,500 $24,550,337 0 $0
2019 ARE 0 $0 150,750 $21,576,631 0 $0
2018 ARE 0 $0 167,500 $21,191,705 0 $0
2017 ARE 0 $0 142,893 $17,096,517 0 $0
2016 ARE 0 $0 55,000 $5,486,299 0 $0
2015 ARE 0 $0 65,500 $6,136,866 0 $0
2014 ARE 0 $0 35,000 $2,785,016 0 $0
2013 ARE 0 $0 25,500 $1,776,575 0 $0
2012 ARE 0 $0 44,500 $3,213,407 0 $0
2011 ARE 0 $0 37,500 $2,752,537 0 $0
2010 ARE 0 $0 42,500 $2,943,319 0 $0
2009 ARE 0 $0 142,904 $7,419,028 47,904 $2,284,541
2008 ARE 0 $0 125,243 $7,030,433 0 $0
2007 ARE 0 $0 27,600 $3,027,714 15,100 $434,912
2006 ARE 0 $0 85,000 $7,572,601 52,096 $1,099,958
2005 ARE 0 $0 14,000 $1,059,374 0 $0

Yearly summary of insider trading at Meiragtx Holdings Plc (MGTX) by Marcus Joel S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 MGTX 0 $0 0 $0 12,882 $99,449
2020 MGTX 0 $0 20,381 $294,292 15,459 $87,034

Yearly summary of insider trading at Intra-cellular Therapies, Inc. (ITCI) by Marcus Joel S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ITCI 0 $0 0 $0 7,009 $447,104
2024 ITCI 0 $0 26,328 $1,812,235 38,324 $1,818,185
2022 ITCI 0 $0 40,000 $2,203,350 14,189 $0
2021 ITCI 0 $0 33,539 $1,305,758 40,000 $1,298,600
2020 ITCI 0 $0 66,899 $1,340,461 14,005 $0
2019 ITCI 0 $0 0 $0 20,000 $249,000
2018 ITCI 0 $0 32,000 $581,579 0 $0
2017 ITCI 0 $0 0 $0 95,000 $242,155
2015 ITCI 0 $0 92,700 $5,041,360 15,000 $17,400

Yearly summary of insider trading at Applied Therapeutics, Inc. (APLT) by Marcus Joel S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 APLT 0 $0 0 $0 12,375 $12,993
2022 APLT 0 $0 0 $0 38,244 $40,156
2020 APLT 500 $22,750 40,000 $1,814,492 0 $0
2019 APLT 150,000 $1,500,000 0 $0 0 $0

Yearly summary of insider trading at Korro Bio, Inc. (FREQ) by Marcus Joel S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 FREQ 0 $0 0 $0 37,116 $125,080
2020 FREQ 55,555 $999,990 82,509 $2,298,489 0 $0

Yearly summary of insider trading at Rexford Industrial Realty, Inc. (NSYE: REXR) by Marcus Joel S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 NSYE: REXR 10,000 $140,000 0 $0 0 $0

Yearly summary of insider trading at Atara Biotherapeutics, Inc. (ATRA) by Marcus Joel S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 ATRA 0 $0 82,590 $3,022,621 62,500 $1,210,625
2018 ATRA 0 $0 10,000 $363,500 0 $0
2015 ATRA 4,000 $118,285 0 $0 0 $0
2014 ATRA 150,000 $1,650,000 0 $0 0 $0


Insider trading activities at 7 companies by Marcus Joel S:

1. Alexandria Real Estate Equities, Inc. (ARE)

2. Meiragtx Holdings Plc (MGTX)

3. Intra-cellular Therapies, Inc. (ITCI)

4. Applied Therapeutics, Inc. (APLT)

5. Korro Bio, Inc. (FREQ)

6. Rexford Industrial Realty, Inc. (NSYE: REXR)

7. Atara Biotherapeutics, Inc. (ATRA)

Table 1. Insider trading of Alexandria Real Estate Equities, Inc. (ARE) by Marcus Joel S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-02-26 ARE Sale 7,500 118.92 891,900
2023-05-08 ARE Sale 7,500 122.20 916,500
2023-02-07 ARE Sale 9,000 168.00 1,512,000
2022-12-12 ARE Sale 6,500 150.00 975,000
2021-08-09 ARE Sale 7,500 207.61 1,557,075
2021-08-02 ARE Sale 5,000 202.63 1,013,150
2021-07-28 ARE Sale 5,000 200.02 1,000,100
2021-07-29 ARE Sale 15,000 200.00 3,000,000
2021-05-03 ARE Sale 15,000 180.33 2,704,950
2021-05-04 ARE Sale 5,000 180.41 902,050
2020-08-17 ARE Sale 7,500 172.51 1,293,862
2020-08-03 ARE Sale 15,000 176.26 2,643,900
2020-07-31 ARE Sale 30,000 175.24 5,257,200
2020-06-05 ARE Sale 25,000 156.41 3,910,250
2020-05-05 ARE Sale 25,000 152.88 3,821,925
2020-04-30 ARE Sale 10,000 156.82 1,568,200
2020-02-12 ARE Sale 35,000 173.00 6,055,000
2019-09-27 ARE Sale 7,500 154.49 1,158,675
2019-09-06 ARE Sale 9,750 152.75 1,489,312
2019-08-08 ARE Sale 15,000 146.65 2,199,750
2019-08-09 ARE Sale 10,000 144.85 1,448,500
2019-08-02 ARE Sale 15,000 144.80 2,172,000
2019-08-01 ARE Sale 5,000 146.00 730,000
2019-05-08 ARE Sale 8,500 140.67 1,195,695
2019-05-02 ARE Sale 15,000 142.03 2,130,450
2019-03-27 ARE Sale 25,000 142.39 3,559,749
2019-03-28 ARE Sale 20,000 142.41 2,848,300
2019-02-15 ARE Sale 10,000 134.41 1,344,100
2019-02-07 ARE Sale 10,000 130.01 1,300,100
2018-12-11 ARE Sale 10,000 126.26 1,262,600
2018-11-30 ARE Sale 5,000 124.25 621,250
2018-12-03 ARE Sale 5,000 125.00 625,000
2018-11-06 ARE Sale 5,000 122.81 614,050
2018-11-01 ARE Sale 10,000 123.02 1,230,200
2018-08-20 ARE Sale 10,000 128.38 1,283,800
2018-08-02 ARE Sale 29,500 126.87 3,742,665
2018-05-10 ARE Sale 13,000 130.00 1,690,000
2018-05-07 ARE Sale 5,000 128.56 642,800
2018-05-08 ARE Sale 15,000 128.52 1,927,800
2018-05-04 ARE Sale 12,000 127.84 1,534,080
2018-05-03 ARE Sale 13,000 127.17 1,653,210
2018-02-15 ARE Sale 5,000 120.86 604,300
2018-02-01 ARE Sale 20,000 125.91 2,518,100
2018-02-02 ARE Sale 10,000 124.19 1,241,850
2017-12-04 ARE Sale 27,500 129.60 3,564,000
2017-11-30 ARE Sale 13,000 126.91 1,649,830
2017-09-25 ARE Sale 25,000 118.99 2,974,750
2017-08-15 ARE Sale 15,500 121.16 1,877,980
2017-08-04 ARE Sale 893 122.03 108,972
2017-08-03 ARE Sale 13,000 121.16 1,575,080
2017-05-10 ARE Sale 5,000 114.77 573,850
2017-05-04 ARE Sale 14,000 112.92 1,580,880
2017-03-17 ARE Sale 9,500 110.37 1,048,515
2017-02-07 ARE Sale 1,500 113.40 170,100
2017-02-06 ARE Sale 5,000 112.36 561,800
2017-02-02 ARE Sale 13,000 108.52 1,410,760
2016-11-03 ARE Sale 30,000 103.58 3,107,400
2016-05-06 ARE Sale 10,000 94.82 948,199
2016-05-05 ARE Sale 15,000 95.38 1,430,700
2015-12-17 ARE Sale 4,000 90.91 363,640
2015-12-11 ARE Sale 4,000 88.80 355,200
2015-12-04 ARE Sale 5,000 90.68 453,400
2015-08-07 ARE Sale 5,000 92.08 460,400
2015-08-10 ARE Sale 5,000 92.49 462,450
2015-06-15 ARE Sale 5,000 91.17 455,850
2015-06-11 ARE Sale 10,000 91.30 913,000
2015-03-18 ARE Sale 9,800 97.84 958,851
2015-03-20 ARE Sale 2,500 101.37 253,425
2015-03-05 ARE Sale 200 98.00 19,600
2015-02-05 ARE Sale 10,000 96.73 967,350
2015-02-06 ARE Sale 5,000 94.74 473,700
2014-12-09 ARE Sale 4,000 91.19 364,772
2014-11-10 ARE Sale 9,000 83.31 749,808
2014-08-14 ARE Sale 2,000 78.38 156,756
2014-08-01 ARE Sale 7,500 78.57 589,275
2014-05-09 ARE Sale 7,500 75.04 562,815
2014-02-18 ARE Sale 5,000 72.32 361,590
2013-09-18 ARE Sale 5,000 65.33 326,640
2013-06-12 ARE Sale 5,000 66.09 330,465
2013-03-25 ARE Sale 2,500 71.39 178,470
2013-03-05 ARE Sale 3,000 72.00 216,000
2013-02-22 ARE Sale 5,000 72.00 360,000
2013-02-13 ARE Sale 5,000 73.00 365,000
2012-12-12 ARE Sale 2,500 70.16 175,395
2012-12-11 ARE Sale 5,000 70.39 351,925
2012-08-14 ARE Sale 3,000 74.00 222,000
2012-08-15 ARE Sale 3,000 74.00 222,000
2012-08-07 ARE Sale 3,000 73.44 220,320
2012-05-17 ARE Sale 4,000 70.45 281,804
2012-05-08 ARE Sale 8,000 74.58 596,656
2012-05-09 ARE Sale 1,500 75.04 112,558
2012-03-27 ARE Sale 1,500 73.04 109,560
2012-03-13 ARE Sale 3,500 72.46 253,624
2012-02-27 ARE Sale 9,500 70.27 667,565
2011-12-13 ARE Sale 2,500 66.00 165,000
2011-11-18 ARE Sale 1,500 66.01 99,009
2011-11-21 ARE Sale 1,500 64.73 97,091
2011-11-02 ARE Sale 5,000 66.00 330,000
2011-11-03 ARE Sale 1,000 66.77 66,767
2011-08-31 ARE Sale 3,000 72.73 218,183
2011-06-13 ARE Sale 4,000 77.00 308,000
2011-06-10 ARE Sale 4,500 76.10 342,450
2011-02-28 ARE Sale 2,000 80.00 160,000
2011-02-07 ARE Sale 10,000 77.04 770,400
2011-02-08 ARE Sale 2,500 78.25 195,637
2010-12-08 ARE Sale 2,500 69.39 173,475
2010-12-01 ARE Sale 5,000 67.41 337,050
2010-11-22 ARE Sale 5,000 67.23 336,150
2010-08-30 ARE Sale 2,500 70.48 176,190
2010-08-18 ARE Sale 2,500 70.34 175,850
2010-08-04 ARE Sale 5,000 72.15 360,730
2010-06-21 ARE Sale 10,000 74.12 741,200
2010-03-16 ARE Sale 2,500 66.07 165,177
2010-03-09 ARE Sale 2,500 64.74 161,847
2010-03-05 ARE Sale 5,000 63.13 315,650
2009-11-17 ARE Sale 5,000 60.30 301,500
2009-11-16 ARE Sale 5,000 60.76 303,800
2009-11-13 ARE Sale 52,904 59.13 3,128,478
2009-11-13 ARE Option Ex 47,904 47.69 2,284,541
2009-11-10 ARE Sale 10,000 60.19 601,900
2009-11-11 ARE Sale 5,000 59.49 297,450
2009-08-20 ARE Sale 5,000 50.00 250,000
2009-08-14 ARE Sale 11,300 50.00 565,000
2009-08-13 ARE Sale 3,700 50.00 185,000
2009-03-12 ARE Sale 10,000 38.69 386,900
2009-03-11 ARE Sale 10,000 37.84 378,400
2009-03-10 ARE Sale 10,000 36.00 360,000
2009-02-26 ARE Sale 15,000 44.04 660,600
2008-12-04 ARE Sale 10,000 38.13 381,300
2008-12-02 ARE Sale 5,000 35.37 176,850
2008-11-26 ARE Sale 10,000 45.23 452,299
2008-11-25 ARE Sale 30,000 41.53 1,245,900
2008-11-24 ARE Sale 30,000 41.12 1,233,660
2008-11-13 ARE Sale 2,500 60.36 150,900
2008-11-12 ARE Sale 2,500 60.00 150,000
2008-11-11 ARE Sale 2,500 60.00 150,000
2008-11-10 ARE Sale 2,500 63.14 157,850
2008-11-04 ARE Sale 5,000 71.03 355,150
2008-08-18 ARE Sale 3,500 108.16 378,560
2008-08-15 ARE Sale 2,500 106.21 265,525
2008-05-21 ARE Sale 900 105.00 94,500
2008-05-15 ARE Sale 5,000 106.00 530,000
2008-05-13 ARE Sale 3,343 104.08 347,939
2008-02-25 ARE Sale 7,500 96.00 720,000
2008-02-21 ARE Sale 2,500 96.00 240,000
2007-11-12 ARE Sale 2,500 98.00 245,000
2007-05-10 ARE Sale 5,000 110.00 550,000
2007-05-09 ARE Sale 5,000 108.71 543,550
2007-02-22 ARE Option Ex 7,500 20.00 150,000
2007-02-21 ARE Option Ex 400 20.00 8,000
2007-02-22 ARE Sale 7,500 113.00 847,500
2007-02-21 ARE Sale 400 113.00 45,200
2007-02-16 ARE Option Ex 7,200 38.46 276,912
2007-02-16 ARE Sale 7,200 110.62 796,464
2006-11-15 ARE Sale 2,500 97.50 243,750
2006-11-13 ARE Sale 2,500 95.00 237,500
2006-08-16 ARE Option Ex 2,096 47.69 99,958
2006-02-24 ARE Option Ex 25,000 20.00 500,000
2006-02-24 ARE Sale 25,000 88.80 2,219,975
2006-02-27 ARE Option Ex 12,600 20.00 252,000
2006-02-27 ARE Sale 12,600 88.66 1,117,116
2006-02-21 ARE Option Ex 12,400 20.00 248,000
2006-02-21 ARE Sale 12,400 89.90 1,114,760
2006-02-17 ARE Sale 10,000 87.77 877,700
2006-02-21 ARE Sale 20,000 88.09 1,761,800
2005-11-16 ARE Sale 500 81.96 40,980
2005-11-07 ARE Sale 2,000 80.55 161,100
2005-11-04 ARE Sale 3,000 80.00 240,000
2005-08-16 ARE Sale 2,000 80.00 160,000
2005-05-18 ARE Sale 6,500 70.35 457,294

Table 2. Insider trading of Meiragtx Holdings Plc (MGTX) by Marcus Joel S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-03-15 MGTX Option Ex 12,882 7.72 99,449
2020-08-10 MGTX Option Ex 15,459 5.63 87,034
2020-08-11 MGTX Sale 7,500 13.86 103,950
2020-08-12 MGTX Sale 7,959 14.15 112,619
2020-05-12 MGTX Sale 4,922 15.79 77,723

Table 3. Insider trading of Intra-cellular Therapies, Inc. (ITCI) by Marcus Joel S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-02-24 ITCI Option Ex 7,009 63.79 447,104
2024-06-23 ITCI Option Ex 1,567 .00 0
2024-02-26 ITCI Option Ex 36,757 49.47 1,818,185
2024-02-26 ITCI Sale 26,328 68.83 1,812,235
2022-08-11 ITCI Sale 10,000 59.22 592,200
2019-06-18 ITCI Option Ex 14,189 .00 0
2022-05-12 ITCI Sale 10,000 55.00 550,000
2022-03-07 ITCI Sale 5,000 54.52 272,600
2022-03-08 ITCI Sale 15,000 52.57 788,550
2021-06-14 ITCI Option Ex 20,000 38.35 767,000
2021-06-14 ITCI Sale 18,289 42.27 773,076
2021-03-02 ITCI Option Ex 20,000 26.58 531,600
2021-03-02 ITCI Sale 15,250 34.93 532,682
2020-06-25 ITCI Option Ex 14,005 .00 0
2020-05-14 ITCI Sale 9,602 20.04 192,424
2020-05-13 ITCI Sale 7,297 20.63 150,537
2020-05-11 ITCI Sale 50,000 19.95 997,500
2019-05-29 ITCI Option Ex 20,000 12.45 249,000
2018-11-12 ITCI Sale 7,000 17.94 125,580
2018-11-09 ITCI Sale 25,000 18.24 455,999
2017-01-26 ITCI Option Ex 95,000 2.55 242,155
2015-12-08 ITCI Sale 22,700 54.80 1,243,960
2015-12-04 ITCI Sale 30,000 55.96 1,678,800
2015-12-07 ITCI Sale 40,000 52.97 2,118,600
2015-03-31 ITCI Option Ex 15,000 1.16 17,400

Table 4. Insider trading of Applied Therapeutics, Inc. (APLT) by Marcus Joel S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-09-15 APLT Option Ex 12,375 1.05 12,993
2022-09-14 APLT Option Ex 38,244 1.05 40,156
2020-05-13 APLT Sale 25,000 46.61 1,165,250
2020-05-14 APLT Sale 9,177 43.18 396,262
2020-05-15 APLT Sale 5,823 43.45 252,980
2020-01-28 APLT Buy 500 45.50 22,750
2019-05-16 APLT Buy 150,000 10.00 1,500,000

Table 5. Insider trading of Korro Bio, Inc. (FREQ) by Marcus Joel S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-03-25 FREQ Option Ex 37,116 3.37 125,080
2020-12-21 FREQ Sale 10,000 30.35 303,520
2020-12-22 FREQ Sale 20,000 33.29 665,780
2020-12-18 FREQ Sale 19,700 36.06 710,480
2020-07-20 FREQ Buy 55,555 18.00 999,990
2020-05-21 FREQ Sale 5,000 18.81 94,055
2020-05-20 FREQ Sale 5,000 18.76 93,795
2020-05-19 FREQ Sale 7,809 18.40 143,669
2020-05-18 FREQ Sale 15,000 19.15 287,190

Table 6. Insider trading of Rexford Industrial Realty, Inc. (NSYE: REXR) by Marcus Joel S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-07-24 NSYE: REXR Buy 10,000 14.00 140,000

Table 7. Insider trading of Atara Biotherapeutics, Inc. (ATRA) by Marcus Joel S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-03-15 ATRA Sale 20,000 38.25 765,000
2019-02-27 ATRA Option Ex 62,500 19.37 1,210,625
2019-02-28 ATRA Sale 62,590 36.07 2,257,621
2018-11-07 ATRA Sale 10,000 36.35 363,500
2015-03-10 ATRA Buy 1,500 29.99 44,985
2015-03-09 ATRA Buy 2,500 29.32 73,300
2014-10-21 ATRA Buy 150,000 11.00 1,650,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Marcus Joel S (Officer of Intra-cellular Therapies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.